These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10740153)

  • 1. Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.
    Fogel RI; Herre JM; Kopelman HA; Kowey PR; Trohman RG; Fineberg N; Prystowsky EN
    Am Heart J; 2000 Apr; 139(4):690-5. PubMed ID: 10740153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
    Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
    Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G; Greene HL
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias.
    Kowey PR; Marinchak RA; Rials SJ; Rubin AM; Smith L
    Am Heart J; 1993 Jun; 125(6):1628-32. PubMed ID: 8498304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
    Van Herendael H; Dorian P
    Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
    Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
    Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
    Domanski MJ; Sakseena S; Epstein AE; Hallstrom AP; Brodsky MA; Kim S; Lancaster S; Schron E
    J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.
    Levine JH; Massumi A; Scheinman MM; Winkle RA; Platia EV; Chilson DA; Gomes A; Woosley RL
    J Am Coll Cardiol; 1996 Jan; 27(1):67-75. PubMed ID: 8522712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning more about indications for implantable cardioverter-defibrillators.
    Myerburg RJ; Castellanos A
    J Am Coll Cardiol; 1999 Oct; 34(4):1096-8. PubMed ID: 10520796
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.
    Schläpfer J; Rapp F; Kappenberger L; Fromer M
    J Am Coll Cardiol; 2002 Jun; 39(11):1813-9. PubMed ID: 12039497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation.
    Hohnloser SH
    Am J Cardiol; 1999 Nov; 84(9A):56R-62R. PubMed ID: 10568661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous amiodarone.
    Kowey PR; Marinchak RA; Rials SJ; Filart RA
    J Am Coll Cardiol; 1997 May; 29(6):1190-8. PubMed ID: 9137212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D, L-sotalol.
    Boriani G; Biffi M; Frabetti L; Maraschi M; Branzi A
    Heart Lung; 2000; 29(6):412-6. PubMed ID: 11080321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone.
    Kavesh NG; Olsovsky MR; Freudenberger RS; Conte JV; Peters RW; Shorofsky SR; Gold MR
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):665-7. PubMed ID: 10234721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
    N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.